Eton Pharmaceuticals Inc. announced that it has named Sean Brynjelsen as its chief executive officer. The new CEO is to develop and execute a strategy to drive near and long-term growth through the development of Eton's branded product candidate pipeline and by acquiring and in-licensing new products. He has more than 20 years of leadership experience in the pharmaceutical industry with companies including Sagent Pharmaceuticals, Akorn Pharmaceuticals, Hospira and Baxter. Most recently, he served as executive vice president of Business Development for Sagent. Prior to his tenure at Sagent, he was senior vice president, Global Business Development for Akorn.